These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture. Flint OP; Masters BA; Gregg RE; Durham SK Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829 [TBL] [Abstract][Full Text] [Related]
23. Pleiotropic effects of statins on the vascular tissue. Ikeda U; Shimada K Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664 [TBL] [Abstract][Full Text] [Related]
24. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809 [TBL] [Abstract][Full Text] [Related]
25. Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells. Kaneda T; Tsuruoka S; Fujimura A Eur J Pharmacol; 2010 Dec; 649(1-3):38-43. PubMed ID: 20851116 [TBL] [Abstract][Full Text] [Related]
26. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Luan Z; Chase AJ; Newby AC Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of migration and proliferation of rat vascular smooth muscle cells by a new HMG-CoA reductase inhibitor, pitavastatin. Kohno M; Shinomiya K; Abe S; Noma T; Kondo I; Oshita A; Takeuchi H; Takagi Y; Yukiiri K; Mizushige K; Ohmori K Hypertens Res; 2002 Mar; 25(2):279-85. PubMed ID: 12047044 [TBL] [Abstract][Full Text] [Related]
28. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering. Hughes AD J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802 [TBL] [Abstract][Full Text] [Related]
29. Influence of HMG-CoA reductase inhibitors on leptin-induced endothelial cell proliferation, migration, and capillary-like tube formation. Burgazli KM; Stein NI; Mericliler M; Parahuleva M; Erdogan A Postgrad Med; 2014 May; 126(3):231-8. PubMed ID: 24918807 [TBL] [Abstract][Full Text] [Related]
31. [The pharmacology of the statins: the evidence of a direct antiatherosclerotic action]. Raiteri M; Arnaboldi L; Quarato P; Paoletti R; Fumagalli R; Corsini A Ann Ital Med Int; 1995 Oct; 10 Suppl():35S-42S. PubMed ID: 8562263 [TBL] [Abstract][Full Text] [Related]
32. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway. Fouty BW; Rodman DM Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884 [TBL] [Abstract][Full Text] [Related]
33. Simvastatin enhanced sodium nitroprusside-induced apoptosis of smooth muscle cells. An involvement of geranylgeraniol. Fujita H; Shimotsuura S; Yanagisawa A; Morita I; Murota S; Ishikawa K Atherosclerosis; 2000 Feb; 148(2):309-15. PubMed ID: 10657567 [TBL] [Abstract][Full Text] [Related]
34. Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Corsini A; Verri D; Raiteri M; Quarato P; Paoletti R; Fumagalli R Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):420-8. PubMed ID: 7749852 [TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells. Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058 [TBL] [Abstract][Full Text] [Related]
37. Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor. Bischoff H; Angerbauer R; Bender J; Bischoff E; Faggiotto A; Petzinna D; Pfitzner J; Porter MC; Schmidt D; Thomas G Atherosclerosis; 1997 Nov; 135(1):119-30. PubMed ID: 9395280 [TBL] [Abstract][Full Text] [Related]
38. Preclinical and clinical pharmacology of cerivastatin. Bischoff H; Heller AH Am J Cardiol; 1998 Aug; 82(4B):18J-25J. PubMed ID: 9737642 [TBL] [Abstract][Full Text] [Related]
39. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957 [TBL] [Abstract][Full Text] [Related]
40. Protective effect of propylthiouracil independent of its hypothyroid effect on atherogenesis in cholesterol-fed rabbits: PTEN induction and inhibition of vascular smooth muscle cell proliferation and migration. Chen WJ; Lin KH; Lai YJ; Yang SH; Pang JH Circulation; 2004 Sep; 110(10):1313-9. PubMed ID: 15326060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]